These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37278240)

  • 1. Rising tide of NAFLD in youth: A warning bell and call to action.
    Xanthakos S
    Hepatology; 2023 Oct; 78(4):1017-1019. PubMed ID: 37278240
    [No Abstract]   [Full Text] [Related]  

  • 2. Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD).
    Schattenberg JM; Bergheim I
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30862016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic Fatty Liver Disease in Children.
    Muzurović E; Polyzos SA; Mikhailidis DP; Borozan S; Novosel D; Cmiljanić O; Kadić N; Mantzoros CS
    Curr Vasc Pharmacol; 2023; 21(1):4-25. PubMed ID: 36411561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A call to action for fatty liver disease.
    Mantovani A; Valenti L
    Liver Int; 2021 Jun; 41(6):1182-1185. PubMed ID: 34002475
    [No Abstract]   [Full Text] [Related]  

  • 5. A brief review on the rising incidence of chronic kidney diseases and non-alcoholic fatty liver disease.
    Nagy J; Kovács T
    Physiol Int; 2019 Dec; 106(4):305-310. PubMed ID: 31906711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: NAFLD in HIV infection--call for action.
    Bulteel N; Leen C
    Aliment Pharmacol Ther; 2015 Mar; 41(6):590. PubMed ID: 25659209
    [No Abstract]   [Full Text] [Related]  

  • 7. The rising incidence of nonalcoholic fatty liver disease.
    Wisocky J; Paul S
    Nurse Pract; 2017 Jul; 42(7):14-20. PubMed ID: 28562448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation.
    Lonardo A; Mantovani A; Petta S; Carraro A; Byrne CD; Targher G
    Nat Rev Endocrinol; 2022 Oct; 18(10):638-650. PubMed ID: 35840803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: NAFLD in HIV infection--call for action. Authors' reply.
    Vodkin I; Loomba R
    Aliment Pharmacol Ther; 2015 Mar; 41(6):591. PubMed ID: 25659210
    [No Abstract]   [Full Text] [Related]  

  • 10. Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study.
    Chang Y; Ryu S; Sung KC; Cho YK; Sung E; Kim HN; Jung HS; Yun KE; Ahn J; Shin H; Wild SH; Byrne CD
    Gut; 2019 Sep; 68(9):1667-1675. PubMed ID: 30472683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-alcoholic fatty liver disease (NAFLD)].
    Rau M; Weiss J; Geier A
    Dtsch Med Wochenschr; 2015 Jul; 140(14):1051-5. PubMed ID: 26182253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of oxidized lipid species in insulin resistance and NASH in children.
    Santoro N; Feldstein AE
    Front Endocrinol (Lausanne); 2022; 13():1019204. PubMed ID: 36263326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Cardiovascular Risk Factors and Metabolic Syndrome with non-alcoholic and alcoholic fatty liver disease: a retrospective analysis.
    Han AL
    BMC Endocr Disord; 2021 May; 21(1):91. PubMed ID: 33933056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes.
    Sarkar M; Grab J; Dodge JL; Gunderson EP; Rubin J; Irani RA; Cedars M; Terrault N
    J Hepatol; 2020 Sep; 73(3):516-522. PubMed ID: 32531415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Rising Tide of Nonalcoholic Fatty Liver Disease: How Much Time Until the Flood Reaches Our Coast?
    Mazzarelli C; Angrisani D; Viganò R
    Clin Gastroenterol Hepatol; 2021 Jun; 19(6):1299. PubMed ID: 33248075
    [No Abstract]   [Full Text] [Related]  

  • 16. Sugar sweetened beverages and fatty liver disease: Rising concern and call to action.
    Abdelmalek MF; Day C
    J Hepatol; 2015 Aug; 63(2):306-8. PubMed ID: 26036988
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical features and metabolic complications for non-alcoholic fatty liver disease (NAFLD) in youth with obesity.
    Barbieri E; Santoro N; Umano GR
    Front Endocrinol (Lausanne); 2023; 14():1062341. PubMed ID: 36733529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease.
    Majumdar A; Tsochatzis EA
    Metabolism; 2020 Oct; 111S():154291. PubMed ID: 32531295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for non-alcoholic fatty liver disease in children and adolescents with type 1 diabetes mellitus: a cross-sectional analysis.
    Kummer S; Klee D; Kircheis G; Friedt M; Schaper J; Häussinger D; Mayatepek E; Meissner T
    Eur J Pediatr; 2017 Apr; 176(4):529-536. PubMed ID: 28213828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease.
    Powell EE; Wong VW; Rinella M
    Lancet; 2021 Jun; 397(10290):2212-2224. PubMed ID: 33894145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.